Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / GENOMICS IMMUN
-
Number of holders
-
48
-
Total 13F shares, excl. options
-
2,165,537
-
Shares change
-
+7,991
-
Total reported value, excl. options
-
$44,367,995
-
Value change
-
-$285,218
-
Number of buys
-
22
-
Number of sells
-
27
-
Price
-
$20.49
Institutional Holders of ISHARES TR - GENOMICS IMMUN (IDNA) as of Q1 2025
As of 31 Mar 2025 ISHARES TR - GENOMICS IMMUN (IDNA) had 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,165,537 shares of stock of the company.
Largest 10 holders included UBS Group AG, MORGAN STANLEY, Wharton Business Group, LLC, BANK OF AMERICA CORP /DE/, RAYMOND JAMES FINANCIAL INC, Clearwater Capital Advisors, LLC, ROYAL BANK OF CANADA, AMERIPRISE FINANCIAL INC, Lido Advisors, LLC, and CORA CAPITAL ADVISORS LLC.
This table shows 64 institutional shareholders of the security as of 31 Mar 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.